Stryker Corporation

SYKHealthcare

Sentinellis Health Score

10/10

Financially healthy

Market Cap

$121.8B

Revenue

$25.1B

P/E Ratio

36.8x

AI Summary

Stryker develops and sells medical devices for hospitals and doctors in two main segments: MedSurg/Neurotechnology (surgical tools, emergency equipment, stroke treatment devices, robotics) and Orthopaedics (hip/knee/shoulder implants, the Mako robotic surgery platform) [Yahoo Finance]. They operate in approximately 61 countries through their own sales teams and third-party distributors [Yahoo Finance].

Stryker Corporation is a $121.8 billion medical technology company that makes surgical equipment, robotic systems, and joint replacement implants sold to hospitals worldwide [Yahoo Finance]. The company reported strong revenue growth of +11.2% year-over-year to $25.1 billion, though recent news notes Q1 2026 earnings missed estimates due to a cyber incident [Yahoo Finance]. Financially, Stryker scores 10.0/10 for health with solid free cash flow of $4.3 billion, but the stock has dropped 21.4% over the past year [Yahoo Finance].

Stryker is financially robust with excellent margins, strong cash generation, and low leverage.

Confidence8/10